Published in Psychosomatics on September 04, 2003
Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev (2011) 5.30
The impact of statins on psychological wellbeing: a systematic review and meta-analysis. BMC Med (2012) 1.05
Neuropsychiatric manifestations of depression in multiple sclerosis: neuroinflammatory, neuroendocrine, and neurotrophic mechanisms in the pathogenesis of immune-mediated depression. Dialogues Clin Neurosci (2007) 0.88
Psychologic disorders and statin use: a propensity score-matched analysis. Pharmacotherapy (2013) 0.81
Specific alterations in plasma proteins during depressed, manic, and euthymic states of bipolar disorder. Braz J Med Biol Res (2015) 0.80
Statins, mood, sleep, and physical function: a systematic review. Eur J Clin Pharmacol (2014) 0.77
Cholesterol, mood, and vascular health: Untangling the relationship: Does low cholesterol predispose to depression and suicide, or vice versa? Curr Psychiatr (2010) 0.76
Screening, diagnosis & monitoring of depression/distress in CHF patients. Heart Fail Rev (2007) 0.75
Cell aging in relation to stress arousal and cardiovascular disease risk factors. Psychoneuroendocrinology (2005) 3.08
Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder. Am J Hum Genet (2003) 3.02
Leukocyte telomere length in major depression: correlations with chronicity, inflammation and oxidative stress--preliminary findings. PLoS One (2011) 2.30
Extended nortriptyline and psychological treatment for cigarette smoking. Am J Psychiatry (2004) 1.87
Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS). Front Neuroendocrinol (2008) 1.87
Overrepresentation of rare variants in a specific ethnic group may confuse interpretation of association analyses. Hum Mol Genet (2006) 1.84
Influences of mood, depression history, and treatment modality on outcomes in smoking cessation. J Consult Clin Psychol (2004) 1.82
Intensive meditation training, immune cell telomerase activity, and psychological mediators. Psychoneuroendocrinology (2010) 1.73
Partitioning the heritability of Tourette syndrome and obsessive compulsive disorder reveals differences in genetic architecture. PLoS Genet (2013) 1.68
Dynamics of telomerase activity in response to acute psychological stress. Brain Behav Immun (2009) 1.68
Of sound mind and body: depression, disease, and accelerated aging. Dialogues Clin Neurosci (2011) 1.63
Genomewide linkage disequilibrium mapping of severe bipolar disorder in a population isolate. Am J Hum Genet (2002) 1.62
Depression gets old fast: do stress and depression accelerate cell aging? Depress Anxiety (2010) 1.58
Varenicline versus bupropion SR or placebo for smoking cessation: a pooled analysis. Am J Health Behav (2008) 1.52
Extended treatment of older cigarette smokers. Addiction (2009) 1.48
Psychological intervention and antidepressant treatment in smoking cessation. Arch Gen Psychiatry (2002) 1.47
Stress and telomere biology: a lifespan perspective. Psychoneuroendocrinology (2013) 1.46
Glucocorticoids. Mood, memory, and mechanisms. Ann N Y Acad Sci (2009) 1.27
Stress appraisals and cellular aging: a key role for anticipatory threat in the relationship between psychological stress and telomere length. Brain Behav Immun (2012) 1.22
Greater endogenous estrogen exposure is associated with longer telomeres in postmenopausal women at risk for cognitive decline. Brain Res (2010) 1.16
Low serum IL-10 concentrations and loss of regulatory association between IL-6 and IL-10 in adults with major depression. J Psychiatr Res (2009) 1.15
Divergent trajectories of physical, cognitive, and psychosocial aging in schizophrenia. Schizophr Bull (2011) 1.14
Why genetic investigation of psychiatric disorders is so difficult. Curr Opin Genet Dev (2004) 1.12
Good stress, bad stress and oxidative stress: insights from anticipatory cortisol reactivity. Psychoneuroendocrinology (2013) 1.12
Eleven-year outcomes from an integrated residency program to train research psychiatrists. Acad Med (2013) 1.07
Association between maternal smoking and increased symptom severity in Tourette's syndrome. Am J Psychiatry (2006) 1.05
Dysregulated diurnal cortisol pattern is associated with glucocorticoid resistance in women with major depressive disorder. Biol Psychol (2013) 1.03
Cost-effectiveness of bupropion, nortriptyline, and psychological intervention in smoking cessation. J Behav Health Serv Res (2005) 1.03
Longitudinal analysis of abstinence-specific social support and smoking cessation. Health Psychol (2009) 1.03
Tic symptom profiles in subjects with Tourette Syndrome from two genetically isolated populations. Biol Psychiatry (2006) 1.02
Genetic studies of neuropsychiatric disorders in Costa Rica: a model for the use of isolated populations. Psychiatr Genet (2004) 1.01
Serum BDNF levels before treatment predict SSRI response in depression. Prog Neuropsychopharmacol Biol Psychiatry (2011) 0.98
Using extended cognitive behavioral treatment and medication to treat dependent smokers. Am J Public Health (2011) 0.97
Recent trends in american board of psychiatry and neurology psychiatric subspecialties. Acad Psychiatry (2011) 0.97
Adverse consequences of glucocorticoid medication: psychological, cognitive, and behavioral effects. Am J Psychiatry (2014) 0.95
CNV analysis in Tourette syndrome implicates large genomic rearrangements in COL8A1 and NRXN1. PLoS One (2013) 0.94
Cross-disorder genome-wide analyses suggest a complex genetic relationship between Tourette's syndrome and OCD. Am J Psychiatry (2014) 0.90
Physical activity moderates effects of stressor-induced rumination on cortisol reactivity. Psychosom Med (2011) 0.88
When blue turns to grey: do stress and depression accelerate cell aging? World J Biol Psychiatry (2008) 0.87
Repeated psychological stress testing in stimulant-dependent patients. Prog Neuropsychopharmacol Biol Psychiatry (2005) 0.87
Spontaneous brain activity in combat related PTSD. Neurosci Lett (2013) 0.87
Heritability and clinical features of multigenerational families with obsessive-compulsive disorder and hoarding. Am J Med Genet B Neuropsychiatr Genet (2007) 0.86
The Association Between Psychiatric Disorders and Telomere Length: A Meta-Analysis Involving 14,827 Persons. Psychosom Med (2016) 0.86
Altering cortisol level does not change the pleasurable effects of methamphetamine in humans. Neuropsychopharmacology (2003) 0.84
Response to Zhang et al. (2005): loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron 45, 11-16. Neuron (2005) 0.84
A comparative study of obsessive-compulsive disorder in Costa Rica and the United States. Depress Anxiety (2008) 0.83
Serum brain-derived neurotrophic factor predicts responses to escitalopram in chronic posttraumatic stress disorder. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.83
The American Psychiatric Association Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia. Am J Psychiatry (2016) 0.83
Cellular aging in depression: Permanent imprint or reversible process?: An overview of the current evidence, mechanistic pathways, and targets for interventions. Bioessays (2014) 0.82
Genetic mapping using haplotype and model-free linkage analysis supports previous evidence for a locus predisposing to severe bipolar disorder at 5q31-33. Am J Med Genet B Neuropsychiatr Genet (2004) 0.81
Older versus younger treatment-seeking smokers: differences in smoking behavior, drug and alcohol use, and psychosocial and physical functioning. Nicotine Tob Res (2008) 0.81
Higher fasting glucose levels are associated with reduced circulating angiogenic cell migratory capacity among healthy individuals. Am J Cardiovasc Dis (2011) 0.80
Belief about drug assignment and abstinence in treatment of cigarette smoking using nortriptyline. Nicotine Tob Res (2007) 0.80
BDNF serum concentrations show no relationship with diagnostic group or medication status in neurodegenerative disease. Curr Alzheimer Res (2012) 0.79
Chronic pregnenolone effects in normal humans: attenuation of benzodiazepine-induced sedation. Psychoneuroendocrinology (2004) 0.78
Neurotransmitters, neurosteroids and neurotrophins: new models of the pathophysiology and treatment of depression. World J Biol Psychiatry (2003) 0.77
Benzodiazepines in schizophrenia: prefrontal cortex atrophy predicts clinical response to alprazolam augmentation. World J Biol Psychiatry (2002) 0.77
Pharmacogenetics of monoamine transporters. Pharmacogenomics (2003) 0.77
Prevalence and clinical correlates of explosive outbursts in Tourette syndrome. Psychiatry Res (2012) 0.77
Genetic linkage in bipolar disorder. CNS Spectr (2003) 0.76
Comorbidity of bipolar disorder and substance abuse in Costa Rica: pedigree- and population-based studies. J Affect Disord (2002) 0.76
Genome-wide linkage analysis of obsessive-compulsive disorder implicates chromosome 1p36. Biol Psychiatry (2012) 0.75
The ABPN Maintenance of Certification Program for psychiatrists: past history, current status, and future directions. Acad Psychiatry (2008) 0.75
Double-blind antiglucocorticoid treatment in schizophrenia and schizoaffective disorder: a pilot study. World J Biol Psychiatry (2002) 0.75